| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/10/2003 | CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | CA2467521A1 Antibodies that immunospecifically bind to blys |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/09/2003 | EP1325957A2 Recombinant papilloma virus L1 |
| 07/09/2003 | EP1325956A1 Plant lesion formation suppressing gene, sp17 and use theriof |
| 07/09/2003 | EP1325932A2 Anti-vegf antibodies |
| 07/09/2003 | EP1325338A2 Diagnosis and treatment of alzheimer's disease |
| 07/09/2003 | EP1325336A2 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/09/2003 | EP1325130A2 Nogo receptor homologs |
| 07/09/2003 | EP1325129A2 Identification of a new cytotoxic activity from the ink of aplysia punctata |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325115A2 Cytokine receptor zcytor17 |
| 07/09/2003 | EP1325033A2 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 07/09/2003 | EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325023A1 Method for modifying a protein structure |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324772A2 Methods for treating disorders of the female reproductive system |
| 07/09/2003 | EP1324768A2 Vaccines for proliferative ileitis |
| 07/09/2003 | EP1324765A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP1000177A4 Synthetic antigen for the detection of antibodies immunoreactive with hiv virus |
| 07/09/2003 | EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | EP0668924B1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | EP0511308B2 Chimeric immunoglobulin for cd4 receptors |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428354A Wheat high-molecular-weight glutelin subunit monoclonal antibody and its hybrid tumor cell line |
| 07/09/2003 | CN1428353A Antihuman hemoglobin monoclonal antibody |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/08/2003 | US6590140 Transgenic plant which expresses a polypeptide comprising given amino acid sequence; iron uptake; can be used to remove pollutants from soil or as nutritional supplements to treat iron- or zinc-deficiency |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590080 Catalytic antibodies and a method of producing same |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589756 Immunoassays using anti-allotypic monoclonal antibodies |
| 07/08/2003 | US6589755 Assay for quantifying arthritic conditions |
| 07/08/2003 | US6589746 Method of detecting axonally-derived protein tau in patients with traumatic CNS injury |
| 07/08/2003 | US6589741 Detecting preferential nucleotide sequences in sample; obtain messenger ribonucleic acid sequences, translate, recover polypeptide, incubate with target molecule, evaluate activity of protein |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589528 Contacting monocytes with monoclonal antibody that binds to fusion regulatory Protein-1 exposed on surface of monocytes |
| 07/08/2003 | US6589527 Using binding substance to connect antibodies to target that they normally have no functional specificity for |
| 07/08/2003 | CA2263883C Kuz, a novel family of metalloproteases |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |
| 07/08/2003 | CA2068593C Method for reducing the immunogenicity of antibody variable domains |
| 07/08/2003 | CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") |
| 07/03/2003 | WO2003054550A2 Uses of an endothelial cell receptor |
| 07/03/2003 | WO2003054545A1 Method of detecting antitelomerase antibody |
| 07/03/2003 | WO2003054544A2 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054221A1 Imp dehydrogenase and the use of the same for identifying fungicidally active compounds |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE |
| 07/03/2003 | WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054021A2 Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes |
| 07/03/2003 | WO2003054020A2 Human antibodies against human glycoprotein vi and their use |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054017A2 Mono-and dual chemokine/cytokine constructs |
| 07/03/2003 | WO2003054016A2 Method for cloning of variable domain sequences |
| 07/03/2003 | WO2003054014A2 Apolipoprotein biopolymer markers predictive of alzheimers disease |
| 07/03/2003 | WO2003054013A2 Compositions, methods and kits for detection and quantification of plant and animal source contaminants |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054005A2 Bone polypeptide-1 |
| 07/03/2003 | WO2003053921A2 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | WO2003053473A2 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053465A2 Lyophilized preparation containing antibodies to the egf receptor |
| 07/03/2003 | WO2003053224A2 Novel compositions and methods for cancer |
| 07/03/2003 | WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 07/03/2003 | WO2003018761A3 Compositions and methods for generating antigen-binding units |
| 07/03/2003 | WO2002101009A3 Structural and cytoskeleton-associated proteins |
| 07/03/2003 | WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 07/03/2003 | WO2002076497A3 Method and composition |
| 07/03/2003 | WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor |
| 07/03/2003 | WO2002059604A3 Diagnosis and treatment of multiple sclerosis |
| 07/03/2003 | WO2002050285A3 Histone deacetylase-related gene and protein |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
| 07/03/2003 | WO2002040668A3 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 07/03/2003 | WO2002036761A3 Compositions and methods for the diagnosis of cancer |
| 07/03/2003 | WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/03/2003 | WO2002024888A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | WO2002024733A3 Human polynucleotides and polypeptides encoded thereby |
| 07/03/2003 | WO2002008281A3 Bstp-cad protein and related reagents and methods of use thereof |
| 07/03/2003 | WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/03/2003 | WO2001083750A9 Dendritic cell co-stimulator molecules |
| 07/03/2003 | US20030126643 Manipulation of cellulose and/or beta-1,4-glucan |